On the 7th of May 2002 a conference of the Cancer Research UK Phase I/II Clinical Trials Committee was held to commemorate the achievements of the late Professor Tom Connors in the field of cancer drug development. Tom Connors died on the 4th of February 2002 from the disease he had spent his life studying, and obituaries chronicling his many scientific and personal attributes and contributions have been written ( Double, 2002 ; Newell, 2002 ).
No takes yet. Share an insight, caveat, or question.
Newell et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: